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After publication of the original article, it came to our 
attention that the samples used for the MMPs and 
TIMP-1 measurements were serum samples instead of 
plasma samples. Therefore,
1. Plasma levels of MMPs and TIMP-1 in the title, 
abstract, methods, results and discussion section 
should read serum levels; and
2. In the discussion section the sentence, “Possibly the 
serum measurement does not truly reflect the circu-
lating concentration of MMPs and TIMPs compared 
to the plasma measurement” should be disregarded.
We apologize for any inconvenience.
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